市場調查報告書
商品編碼
1521297
2024-2032年按材料(玻璃、玻璃陶瓷、複合材料等)、類型(粉末、可模塑、顆粒等)、應用(牙科、外科、生物工程等)和地區分類的生物活性材料市場Bioactive Materials Market by Material (Glass, Glass-ceramics, Composite, and Others), Type (Powder, Moldable, Granules, and Others), Application (Dentistry, Surgery, Bioengineering, and Others), and Region 2024-2032 |
IMARC Group年全球生物活性材料市場規模達28億美元。對再生醫學不斷成長的需求、開發具有增強性能的新型和改進的生物活性材料以及生物技術和生命科學領域的不斷改進是推動市場的一些關鍵因素。
生物活性材料是指與生物系統(例如細胞、組織和器官)相互作用的成分。這些材料可以是合成的或天然的,主要用於各種醫療應用,包括組織工程、藥物傳輸和再生醫學。它們可以透過模仿目標組織的細胞外基質(ECM)來促進特定的生物反應,例如細胞黏附、增殖和分化。此外,它們還可以用於藥物輸送,其中材料被設計成隨著時間的推移釋放藥物或治療劑。這對於標靶藥物傳遞非常有用,藥物可以直接釋放到受影響的組織,最大限度地減少副作用並提高療效。因此,它們在全球範圍內獲得了廣泛的關注,因為生物活性材料在醫學領域具有廣泛的應用,並且是推動各種疾病和病症治療的重要工具。一些常見的生物活性材料包括羥基磷灰石和聚己內酯 (PCL),它們廣泛用於骨移植和牙科植入物,並用於創建促進新組織生長的支架。
全球市場主要是由患者和醫療保健專業人員對再生醫學不斷成長的需求所推動的。再加上慢性病在個人中的盛行率不斷增加,導致對創新治療方案的需求不斷成長,這推動了對促進組織再生和修復的生物活性材料的需求。同時,生物活性材料領域的不斷技術進步以及具有增強特性(例如生物相容性、生物可分解性和機械強度)的新型和改進材料的開發正在創造積極的市場前景。此外,為開發新材料和應用而進行的廣泛研發(R&D)活動的投資不斷增加,也是一個成長誘導因素。除此之外,私人和公共機構為升級整體醫療基礎設施而不斷增加的資金正在對市場產生積極影響。同時,生物技術和生命科學領域的不斷進步極大地支持了全球對生物活性材料的需求。其他因素,包括快速城市化、不斷成長的老年人口以及農村和其他地區醫療設施的發展,也對市場產生了積極影響。
The global bioactive materials market size reached US$ 2.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.7 Billion by 2032, exhibiting a growth rate (CAGR) of 11.44% during 2024-2032. The growing demand for regenerative medicine, the development of new and improved bioactive materials with enhanced properties and continuous improvements in the field of biotechnology and life science represent some of the key factors driving the market.
Bioactive materials are constituents that are meant to interact with biological systems, such as cells, tissues, and organs. These materials can be synthetic or natural and are mainly used in a variety of medical applications, including tissue engineering, drug delivery, and regenerative medicine. They can promote specific biological responses, such as cell adhesion, proliferation, and differentiation, by mimicking the extracellular matrix (ECM) of the tissue being targeted. Additionally, they can also be utilized for drug delivery, where the material is designed to release a drug or therapeutic agent over time. This can be useful for targeted drug delivery, where the drug is released directly to the affected tissue, minimizing side effects and improving efficacy. As a result, they are gaining widespread prominence across the globe since bioactive materials have a wide range of applications in the medical field and are an important tool for advancing treatments for various diseases and conditions. Some of the common bioactive materials include hydroxyapatite and polycaprolactone (PCL) that are widely adopted for bone grafts and dental implants and to create scaffolds that promote the growth of new tissue.
The global market is majorly driven by the growing demand for regenerative medicine among patients and healthcare professionals. Coupled with the increasing prevalence of chronic diseases among individuals, leading to a growing need for innovative treatment options, this is providing a boost to the demand for bioactive materials to promote tissue regeneration and repair. Along with this, continual technological advancements in the field of bioactive materials and the development of new and improved materials with enhanced properties, such as biocompatibility, biodegradability, and mechanical strength, are creating a positive market outlook. Furthermore, the growing investments in extensive research and development (R&D) activities to develop new materials and applications are acting as a growth-inducing factor. Apart from this, the escalating funding by private and public agencies to upgrade the overall healthcare infrastructure is impacting the market favorably. Along with this, continuous improvements in the field of biotechnology and life science are significantly supporting the demand for bioactive materials across the globe. Other factors, including rapid urbanization, the growing geriatric population and the development of medical facilities across rural and geographically extended locations, are also positively influencing the market.
IMARC Group provides an analysis of the key trends in each segment of the global bioactive materials market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on material, type and application.
Glass
Glass-ceramics
Composite
Others
The report has provided a detailed breakup and analysis of the bioactive materials market based on the material. This includes glass, glass-ceramics, composites and others. According to the report, glass represented the largest segment.
Powder
Moldable
Granules
Others
A detailed breakup and analysis of the bioactive materials market based on the type has also been provided in the report. This includes powder, moldable, granules and others. According to the report, powder type accounted for the largest market share.
Dentistry
Surgery
Bioengineering
Others
The report has provided a detailed breakup and analysis of the bioactive materials market based on the application. This includes dentistry, surgery, bioengineering and others. According to the report, dentistry application exhibits a clear dominance in the market.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for bioactive materials. Some of the factors driving the North America bioactive materials market included the growing investment in extensive research and development (R&D) activities, the emerging healthcare infrastructure, the development of medical facilities across rural and geographically extended locations, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global bioactive materials market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Arthrex Inc., BBS-Bioactive Bone Substitutes Oyj, Berkeley Advanced Biomaterials, Biomatlante SAS (Advanced Medical Solutions Group Plc), Ceraver, DePuy Synthes Inc. (Johnson & Johnson), Noraker, PULPDENT Corporation, Regenity Biosciences, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.